Page last updated: 2024-09-04

moxifloxacin and imipenem, anhydrous

moxifloxacin has been researched along with imipenem, anhydrous in 47 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (imipenem, anhydrous)	Trials (imipenem, anhydrous)	Recent Studies (post-2010) (imipenem, anhydrous)
3,157	552	1,690	4,784	391	1,397

Protein Interaction Comparison

Protein	Taxonomy	moxifloxacin (IC50)	imipenem, anhydrous (IC50)
Beta-lactamase	Pseudomonas aeruginosa		0.15

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.13)	18.2507
2000's	22 (46.81)	29.6817
2010's	18 (38.30)	24.3611
2020's	6 (12.77)	2.80

Authors

Authors	Studies
Appelbaum, PC; Credito, KL; DeWasse, B; Kosowska-Shick, K; McGhee, P; Pankuch, GA	1
Bouza, E; Cercenado, E; Cuevas, O; Marín, M; Martínez-Alarcón, J; Sánchez-Martínez, M	1
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA	1
Finegold, SM; Golan, Y; Goldstein, EJ; Gorbach, SL; Harrell, LJ; Hecht, DW; Jacobus, NV; Jenkins, SG; McDermott, LA; Pierson, C; Rihs, J; Ruthazer, R; Snydman, DR; Venezia, R; Yu, V	1
Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K	1
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F	1
Brémont, S; Courvalin, P; Damier-Piolle, L; Lambert, T; Magnet, S	1
Lombardo, F; Obach, RS; Waters, NJ	1
Betriu, C; Culebras, E; Gómez, M; López, F; Picazo, JJ; Rodríguez-Avial, I	1
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC	1
Cattoir, V; Nordmann, P; Poirel, L	1
Jacobus, NV; McDermott, LA; Snydman, DR	2
Appelbaum, PC; Ednie, LM; Kosowska-Shick, K; McGhee, P	1
Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE	1
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A	1
Chen, HC; King, CH; Lai, JF; Lauderdale, TL; Shiau, YR	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR	1
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ	1
Chong, Y; Jeong, SH; Kim, MS; Lee, K; Lee, Y; Park, Y; Yong, D	1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Fernando, DM; Gorityala, BK; Goswami, S; Guchhait, G; Kumar, A; Schweizer, F; Zhanel, GG	1
Edlund, C; Nord, CE; Sabouri, S	1
Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A	1
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E	1
Buchheidt, D; Hofheinz, R; Hummel, M	1
Ackermann, G; Beer, J; Blatz, R; Rodloff, AC; Schaumann, R	1
Almassi, GH; Brown, KR; Edmiston, CE; Kehl, KS; Krepel, CJ; Lewis, BD; Loehrl, TA; Seabrook, GR; Smith, TL; Somberg, LB; Towne, JB	1
Gonzalez-Fernandez, F; Patel, NR; Reidy, JJ	1
Dahan, K; Delahousse, M; El Kabbaj, D; Pastural, M; Venditto, M	1
Delgado, J; Diaz, LA; Galvis, V; Gómez, AJ; Tello, A; Valencia, F	1
Holst, O; Lepper, PM; Scheibe, C; Trautmann, M; Wellinghausen, N	1
Freeman, JT; Goh, TL; Jones, KL; Towns, CR; Wong, CS	1
Dalhoff, A; Schubert, S	1
Ding, C; Gao, Z; Horby, P; Jiang, G; Jiang, R; Li, R; Liu, X; Nie, C; Qian, K; Sun, J; Wan, J; Wang, Q; Xiao, Z; Zeng, Z; Zhang, J; Zhang, W	1
Brown-Elliott, BA; Chao, AS; Chiu, CH; Griffith, DE; Leu, HS; Lin, CS; Wu, TL; Wu, TS; Yang, CH	1
Bettoli, V; Join-Lambert, O; Nassif, A	1
Chen, WL; Chu, HS; Hu, FR; Liu, HY; Wang, IJ	1
Khalid, UK; Mathuria, KK; Munjal, SK; Myneedu, VP; Puri, MM; Sarin, R; Singla, N; Singla, R; Verma, A; Vohra, V	1
Fukui, M; Marumo, S; Shirata, M; Tamai, K; Yoshimoto, Y	1
Ikebuchi, K; Imai, K; Kawamura, T; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Ogane, K; Onodera, A; Sakai, J; Takeuchi, S; Tarumoto, N	1
Chonan, M; Fujimoto, Y; Ihara, H; Iwai, M; Kurokawa, K; Misawa, S; Nakamura, A; Ochi, Y; Ohsaka, A; Okabe, T; Shibayama, K; Sumiyoshi, I; Takahashi, K; Takei, S; Togo, S; Watanabe, J	1
Corrales, MI; Galvis, V; Garcia, D; Parra, MM; Rangel, CM; Sánchez-Ávila, R; Tello, A; Varón, CL; Villareal, E; Villarreal, D	1
Arslan, N; Esen, N; Özkarataş, MH; Özkütük, AA	1
Cheng, VC; Chow, KH; Fang, H; Ho, PL; Li, X; Tong, MK; Yan, MK	1

Reviews

3 review(s) available for moxifloxacin and imipenem, anhydrous

Article	Year
Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation. Journal of cataract and refractive surgery, 2005, Volume: 31, Issue:10 Topics: Administration, Topical; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Imipenem; Keratitis; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Middle Aged; Moxifloxacin; Necrosis; Nocardia asteroides; Nocardia Infections; Quinolines; Recurrence	2005
Antibiotic Treatment of Hidradenitis Suppurativa. Dermatologic clinics, 2016, Volume: 34, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin	2016
Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction. Journal of refractive surgery (Thorofare, N.J. : 1995), 2018, Sep-01, Volume: 34, Issue:9 Topics: Administration, Ophthalmic; Administration, Oral; Amikacin; Anti-Bacterial Agents; Clarithromycin; Corneal Surgery, Laser; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Microsurgery; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Myopia; Refraction, Ocular; Surgical Flaps; Tomography, Optical Coherence; Visual Acuity; Young Adult	2018

Other Studies

44 other study(ies) available for moxifloxacin and imipenem, anhydrous

Article	Year
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2 Topics: Amidohydrolases; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Peptides; Pneumococcal Infections; Species Specificity; Streptococcus pneumoniae; Time Factors	2007
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Minocycline; Nocardia; Nocardia Infections; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline	2007
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles	2007
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Time Factors; United States	2007
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae	2007
Antimicrobial susceptibilities and clinical sources of Dialister species. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae	2007
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Multigene Family; Sequence Analysis, DNA; Substrate Specificity	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Spain; Species Specificity; Time Factors	2008
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan	2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids	2008
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests	2008
Comparative antipneumococcal activities of sulopenem and other drugs. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Lactams; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Streptococcus pneumoniae	2009
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests	2009
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline	2010
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Taiwan	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States	2010
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare	2010
Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Positive Cocci; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Republic of Korea	2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction	2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux. Journal of medicinal chemistry, 2016, 09-22, Volume: 59, Issue:18 Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2016
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:3 Topics: Anti-Infective Agents; Aza Compounds; Bacteria, Anaerobic; Cefoxitin; Cephamycins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Moxifloxacin; Ofloxacin; Quinolines; Quinolones; Thienamycins	1998
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. International journal of antimicrobial agents, 2002, Volume: 19, Issue:2 Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin	2002
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001, Volume: 14, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins	2001
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease. Annals of hematology, 2004, Volume: 83, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine	2004
Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA, Bacterial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Imipenem; Kidney; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Reverse Transcriptase Polymerase Chain Reaction	2004
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolines	2005
Intracranial Nocardia recurrence during fluorinated quinolones therapy. Transplant infectious disease : an official journal of the Transplantation Society, 2006, Volume: 8, Issue:3 Topics: Amikacin; Aza Compounds; Brain Abscess; Drug Combinations; Fluoroquinolones; Humans; Imipenem; Kidney Transplantation; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Quinolines; Sulfamethizole; Trimethoprim	2006
Late bacterial keratitis after intracorneal ring segments (Ferrara ring) insertion for keratoconus. Cornea, 2007, Volume: 26, Issue:10 Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Keratoconus; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Prostheses and Implants; Prosthesis Implantation; Quinolines; Staphylococcal Infections; Vancomycin	2007
Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin. Chemotherapy, 2010, Volume: 56, Issue:5 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Ceftazidime; Endotoxins; Escherichia coli; Fluoroquinolones; Imipenem; Kinetics; Moxifloxacin; Quinolines	2010
In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1 Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Ceftaroline; Ceftriaxone; Cephalosporins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline	2011
Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country. The Medical journal of Australia, 2011, Jun-06, Volume: 194, Issue:11 Topics: Acetamides; Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Cycloserine; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Imipenem; Linezolid; Lymph Nodes; Male; Moxifloxacin; Myanmar; New Zealand; Oxazolidinones; Quinolines; Radiography	2011
Activity of moxifloxacin, imipenem, and ertapenem against Escherichia coli, Enterobacter cloacae, Enterococcus faecalis, and Bacteroides fragilis in monocultures and mixed cultures in an in vitro pharmacokinetic/pharmacodynamic model simulating concentrat Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12 Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Load; Bacteroides fragilis; beta-Lactams; Colony Count, Microbial; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Models, Statistical; Moxifloxacin; Pancreas; Pancreatitis, Acute Necrotizing; Quinolines; Regression Analysis	2012
Clinical characteristics of human infection with a novel avian-origin influenza A(H10N8) virus. Chinese medical journal, 2014, Volume: 127, Issue:18 Topics: Aged; Antiviral Agents; Female; Fluoroquinolones; Humans; Imipenem; Influenza A Virus, H10N8 Subtype; Influenza, Human; Male; Middle Aged; Moxifloxacin; Oseltamivir	2014
Postcesarean section wound infection caused by Mycobacterium massiliense. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:6 Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Cesarean Section; Chaperonin 60; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Electrophoresis, Gel, Pulsed-Field; Female; Fluoroquinolones; Humans; Imipenem; Methyltransferases; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Mycobacterium Infections; Nontuberculous Mycobacteria; Pregnancy; Surgical Wound Infection; Teicoplanin	2016
Early efficacy and safety of Bedaquiline and Delamanid given together in a "Salvage Regimen" for treatment of drug-resistant tuberculosis. The Indian journal of tuberculosis, 2019, Volume: 66, Issue:1 Topics: Adult; Cardiotoxicity; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Electrocardiography; Female; Humans; Imipenem; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Salvage Therapy; Sputum; Survival Rate; Tuberculosis, Multidrug-Resistant; Young Adult	2019
In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97 Topics: Actinomycetales Infections; Amikacin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacteriaceae; Sequence Analysis, DNA	2020
Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan. Anaerobe, 2020, Volume: 64 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Blood Culture; DNA Transposable Elements; Doripenem; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Japan; Meropenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin, Tazobactam Drug Combination; Prevalence; Sulbactam; Tertiary Care Centers	2020
The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex. BMC microbiology, 2020, 10-19, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Drug Synergism; Female; Humans; Imipenem; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous	2020
ENDOPHTHALMITIS IN OPHTHALMOLOGICAL REFERRAL CENTRE IN COLOMBIA: AETIOLOGY AND MICROBIAL RESISTANCE. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 2022,Summer, Volume: 78, Issue:4 Topics: Adult; Anti-Bacterial Agents; Colombia; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Imipenem; Male; Moxifloxacin; Referral and Consultation; Retrospective Studies; Vancomycin	2022
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria]. Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Humans; Imipenem; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Tobramycin	2023
Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021. Anaerobe, 2023, Volume: 82 Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Clindamycin; Hong Kong; Imipenem; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; RNA, Ribosomal, 16S	2023